Monitor for the filing of the F-4 registration statement and the subsequent shareholder vote. The key risk is shareholder redemptions, which could reduce the trust cash available to the combined company. Watch for any PIPE investment announcements to backstop the trust.
Price Chart
Executive Summary
Starry Sea Acquisition Corp (SSEA), a blank-check SPAC, announced a definitive merger agreement to acquire SuperiorMed Holdings Limited, a healthcare management and consulting company operating in the UAE. The deal values SuperiorMed at $200 million, with consideration paid entirely in newly issued shares of the post-combination company at $10.00 per share. This is a standard SPAC business combination announcement; the stock will trade on the merger narrative until shareholder approval and regulatory conditions are met.
Key Financial Metrics
Key Facts
- SSEA entered into a definitive merger agreement to acquire SuperiorMed Holdings Limited.
- SuperiorMed is valued at $200 million (Company Net Value).
- Consideration is all-stock: SuperiorMed shareholders will receive Purchaser Ordinary Shares at $10.00 per share.
- The post-combination board will have 5 directors: 1 from SSEA and 4 from SuperiorMed.
- SuperiorMed shareholders and the Sponsor are subject to a 180-day lock-up, with an early release if the stock trades at or above $12.00 for 20 of 30 trading days.
- The merger must close by the later of May 7, 2027, or the end of SSEA's combination period.
Financial Impact
SuperiorMed valued at $200,000,000 in an all-stock transaction. No cash component or PIPE size disclosed.
Risk Factors
- Failure to obtain shareholder approval from SSEA or SuperiorMed.
- High shareholder redemptions depleting the trust account.
- Inability to obtain required regulatory approvals or satisfy closing conditions.
- Failure to complete the restructuring of SuperiorMed's ownership of its Dubai subsidiary before closing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (SSEA) — Batch item 1 | 0001829126-26-009352 |
| Document: 0001829126-26-009352-index-headers.html | 0001829126-26-009351 |
| Document: 0001829126-26-009352-index.html | 0001829126-26-009352 |
| Document: 0001829126-26-009352.txt | 0001829126-26-009352 |
| 8-K Filing (SSEA) — Batch item 5 | 0001829126-26-009351 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 8-K/A | $10.41 | awaiting T+5 | — | $10.41 (−0.00%) |
Oct 20, 2026 6d ago | 8-K | $10.41 | awaiting T+5 | — | $10.41 (+0.00%) |
Oct 16, 2026 10d ago | DEFA14A | $10.41 $10.41 | · 0.00% | ▼ −0.14% | $10.41 (+0.00%) |
Oct 16, 2026 10d ago | 8-K | $10.41 $10.41 | · 0.00% | ▼ −0.14% | $10.41 (+0.00%) |
Oct 9, 2026 17d ago | DEFA14A | $10.99 $10.41 | ▲ +5.28% | ▲ +3.78% | $10.41 (+5.28%) |
Oct 9, 2026 17d ago | 8-K / DEFA14A | $10.99 $10.41 | ▲ +5.28% | ▲ +3.78% | $10.41 (+5.28%) |
Oct 9, 2026 18d ago | DEFA14A | $10.44 $10.40 | ▲ +0.38% | ▼ −1.58% | $10.41 (+0.29%) |
Oct 9, 2026 18d ago | 8-K | $10.44 $10.40 | ▼ −0.38% | ▲ +1.58% | $10.41 (−0.29%) |
Oct 6, 2026 21d ago | SC 13G/A | $10.35 $10.34 | ▼ −0.10% | ▲ +0.04% | $10.41 (+0.58%) |
Sep 21, 2026 5w ago | DEF 14A | $10.35 $10.35 | · 0.00% | ▲ +1.02% | $10.41 (+0.58%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers